020 Profile of BP180 and BP230-specific IgE Autoantibodies in Bullous Pemphigoid

Y. Shih,H. Yuan,J. Zheng,M. Pan
DOI: https://doi.org/10.1016/j.jid.2019.03.096
IF: 7.59
2019-01-01
Journal of Investigative Dermatology
Abstract:Background: Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by autoantibodies against BP180 and BP230. There is emerging evidence that IgE autoantibodies play an important role in the pathogenesis of BP. Objective: To determine the rate of anti-BP180 and anti-BP230 IgE in BP, and to evaluate their diagnostic relevance in BP sera. Methods: We collected serum samples from 156 patients who met the clinical and immunologic, and histologic features consistent with BP. In addition, 10 control individuals were included for comparison. We used commercially available IgG enzyme-linked immunosorbent assay (ELISA) to develop IgG and IgE ELISAs for both BP180 and BP230. A receiver operating characteristic (ROC) curve was used to evaluate the ability of the ELISA to detect anti-BP180 and anti-BP230 IgE autoantibodies. Anti-BP180 IgE and anti-BP230 IgE positivity were conducted using the Spearman’s rank correlation test. The results of IgE ELISAs were statistically compared among various ELISAs. Results: In 156 BP patients, 96 BP patients with elevated level of total IgE (>165.3IU/ml) and 60 BP patients with normal level of total IgE. IgE autoantibodies to BP180 and BP230 were found in 25 and 36 of 96 BP sera, respectively. And, anti-BP180 IgG and anti-BP230 IgG were detected in 82 and 79 of 96 BP sera, respectively. Anti-BP230 IgE autoantibodies, but not anti-BP180 IgE autoantibodies, correlated with total IgE (R=0.6914, P<0.0001). The level of BP230 IgE was significantly higher than the level of BP180 IgE (P=0.0357). Conclusion: The results of this study indicated that most BP patients exhibit elevated IgE levels in the serum. IgE autoantibodies to both BP180 and BP230 can be detected in BP sera. The results of total IgE and anti-BP230 IgE ELISAs are well correlated. In BP patients, the positivity rate of anti-BP230 IgE is higher than anti-BP180 IgE. IgE anti-BP230 autoantibodies seemed to be pathogenic in BP.
What problem does this paper attempt to address?